University of California San Francisco
Give to UCSF
UCSF Nobel laureate Stanley Prusiner, MD, and colleagues have called for Congress to more than quadruple annual federal funding for Alzheimer’s research, saying that with a dedicated effort, there is a chance for a breakthrough against the disease by 2020.
A tiny, translucent juvenile zebrafish, on the hunt for even littler prey, has offered up a big insight into how a specific circuit of nerve cells functions in the brain.
Researchers at the Ernest Gallo Clinic and Research Center at UCSF, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.
As San Francisco prepares to celebrate the 2010 World Series champions with a parade today, UCSF’s Stuart Lustig explains why fans are so excited about the San Francisco Giants.
UCSF Nobel laureate Elizabeth Blackburn, PhD, and researcher Elissa Epel, PhD, are co-authors with UC Davis scientists of a paper showing that the positive psychological changes that occur during meditation training are associated with greater activity of the enzyme telomerase.
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
UCSF Nobel laureate Stanley B. Prusiner, professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation’s highest honor for science and technology.
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will be inducted today into the American Academy of Arts and Sciences, alongside some of the world’s other most distinguished scholars, artists and institutional leaders.
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.
UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).